The Pan-Mass Challenge is a Massachusetts-based bike-a-thon that raises more money for charity than any other single athletic fundraising event in the country. Always held the first weekend in August, the PMC raises funds for Dana-Farber Cancer Institute, a world leader in adult and pediatric cancer treatment and research.
Each summer, thousands of riders and volunteers from 43 states and 12 countries participate in the PMC, all with a common goal: to find a cure for cancer.
100 percent of all rider-raised funds go directly to cancer research and treatment at Dana-Farber and the Jimmy Fund. The PMC is Dana-Farber’s single largest supporter and is 64 percent of the Jimmy Fund’s annual revenue. Since 1980, the PMC has raised $767 million for Dana-Farber.
Since its founding more than 40 years ago, the Pan-Mass Challenge has successfully melded support from committed riders, volunteers, corporate sponsors, and individual contributors. All are essential to the PMC's goal and model: to attain maximum fundraising efficiency while increasing our annual gift. Our hope and aspiration is to provide Dana-Farber Cancer Institute's doctors and researchers with the necessary resources to discover cures for all cancers.
When Billy Starr, PMC Founder and Executive Director, was just 25 years old, his mother, Betty Starr died from melanoma at 49 years old. After a hike with friends along the Appalachian Trail where Billy learned that he could achieve anything to which he committed his mind and body, he organized the first Pan-Mass Challenge in 1980.
The first PMC had just 36 riders and 10 volunteers. This inaugural ride was not perfect; everyone got lost but they accomplished what they set out to do: raise funds for cancer research. The first ride raised $10,200 for Dana-Farber Cancer Institute, where Billy’s mother was treated.
From there, the ride grew exponentially in its number of riders, volunteers, donors, sponsors, and notably, its fundraising efforts. Today, the PMC has more than:
As Dana-Farber Cancer Institute’s largest single contributor, the Pan-Mass Challenge accelerates scientific investigations that inform the development of new therapies and personalized plans, impacting patients across all cancers. PMC dollars provide critical seed funding for clinical trials and innovative studies – research that advances early detection, treatment, and prevention of cancer.”